pharmaceutical
Allergan posts disappointing data in NASH
September 25, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical
It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …
Sanofi’s arthritis treatment Kevzara secures NICE recommendation
September 25, 2017Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab
Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …
‘Super malaria’ sweeps South East Asia
September 25, 2017Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical
There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …
Indivior reaches settlement with Mylan over patent dispute
September 25, 2017Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone
Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …
FDA rejects J&J’s treatment for rheumatoid arthritis
September 25, 2017Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab
Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …
Alnylam soars on likely first RNAi treatment approval
September 22, 2017Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical
Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …
19 deaths from liver drug causes Intercept shares to tumble
September 22, 2017Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical
Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …
NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation
September 22, 2017Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical
Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …
New therapy offers triple threat to HIV virus
September 22, 2017Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …
Weight loss drugs could be used to treat cocaine addiction
September 21, 2017Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical
Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …
Witty, Ex-CEO of GSK, keeps busy with two new roles in two days
September 21, 2017Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical
It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …
Report finds variation in quality of care in GP practices across England
September 21, 2017Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical
Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …
Merck and Pfizer’s joint skin cancer drug gets EU approval
September 21, 2017Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer
Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …
Bayer pulls plug on sterilisation device after numerous complaints
September 21, 2017Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical
Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …
Novartis scores EU approval in acute myeloid leukaemia and advanced systemic mastocytosis
September 20, 2017Research and Development, Sales and Marketing EU, Europe, Novartis, acute myeloid leukaemia, advanced systemic mastocytosis, pharma, pharmaceutical
Novartis has announced that its targeted therapy Rydapt (midostaurin) has received EU approval in the two rare cancer indications: newly …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
